Literature DB >> 16309567

The role of exogenous carbon monoxide in the recovery of post-ischemic cardiac function in buffer perfused isolated rat hearts.

I Bak1, J Varadi, N Nagy, M Vecsernyes, A Tosaki.   

Abstract

Isolated rat hearts were perfused for 10 min with oxygenated buffer and equilibrated with carbon monoxide (CO) of 0.001% and 0.01% before the induction of 30 min global ischemia followed by 120 min of reperfusion. These concentrations of CO significantly improved the post-ischemic recovery of coronary flow (CF), aortic flow (AF), and left ventricular developed pressure (LVDP). The improvement in recovery reflected in the reduction of infarct size and the incidence of reperfusion-induced ventricular fibrillation (VF). Thus, hearts subjected to 0.001% and 0.01% of CO exposure via the perfusion buffer, infarct size was reduced from the CO-free control value of 39% +/- 5% to 21% +/- 3% (*p<0.05) and 18% +/- 4% (*p<0.05), respectively. In the presence of 0.001% and 0.01% CO, the incidence of VF was also reduced from its control value of 92% to 17% (*p<0.05) and 17% (*p<0.05), respectively. Increasing the CO exposure to 0.1% in the buffer, all hearts showed VF combined with ventricular tachycardia or bradycardia and various rhythm disturbances indicating the direct toxic effects of CO on the myocardium. The results show that cardioprotective concentrations (0.01% and 0.001%) of exogenous CO related to an increase in cGMP levels and guanylate cyclase activities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309567

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  7 in total

1.  Positive inotropic effects of carbon monoxide-releasing molecules (CO-RMs) in the isolated perfused rat heart.

Authors:  M D Musameh; B J Fuller; B E Mann; C J Green; R Motterlini
Journal:  Br J Pharmacol       Date:  2006-10-23       Impact factor: 8.739

2.  The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.

Authors:  Hagir B Suliman; Martha Sue Carraway; Abdelwahid S Ali; Chrystal M Reynolds; Karen E Welty-Wolf; Claude A Piantadosi
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 3.  Role of carbon monoxide in cardiovascular function.

Authors:  William Durante; Fruzsina K Johnson; Robert A Johnson
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

4.  Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium.

Authors:  Bela Juhasz; Balazs Varga; Attila Czompa; Istvan Bak; Istvan Lekli; Rudolf Gesztelyi; Judit Zsuga; Adam Kemeny-Beke; Miklos Antal; Levente Szendrei; Arpad Tosaki
Journal:  J Cell Mol Med       Date:  2011-09       Impact factor: 5.310

Review 5.  ArrhythmoGenoPharmacoTherapy.

Authors:  Arpad Tosaki
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

Review 6.  Heme Degradation in Pathophysiology of and Countermeasures to Inflammation-Associated Disease.

Authors:  Donald David Haines; Arpad Tosaki
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

7.  The Effects of Long-Term, Low- and High-Dose Beta-Carotene Treatment in Zucker Diabetic Fatty Rats: The Role of HO-1.

Authors:  Evelin Csepanyi; Attila Czompa; Peter Szabados-Furjesi; Istvan Lekli; Jozsef Balla; Gyorgy Balla; Arpad Tosaki; Istvan Bak
Journal:  Int J Mol Sci       Date:  2018-04-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.